Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3

被引:358
作者
Ling, H
Boodhoo, A
Hazes, B
Cummings, MD
Armstrong, GD
Brunton, JL
Read, RJ [1 ]
机构
[1] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada
[2] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada
[4] Univ Toronto, Dept Microbiol, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1021/bi971806n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Shiga-like toxin I (SLT-I) is a virulence factor of Escherichia coli strains that cause disease in humans, Like other members of the Shiga toxin family, it consists of an enzymatic (A) subunit and five copies of a binding subunit (the B-pentamer). The R-pentamer binds to a specific glycolipid, globotriaosylceramide (Gb(3)), on the surface of target cells and thereby plays a crucial role in the entry of the toxin. Here we present the crystal structure at 2.8 Angstrom resolution of the SLT-I B-pentamer complexed with an analogue of the Gb(3) trisaccharide, The structure reveals a surprising density of binding sites, with three trisaccharide molecules bound to each B-subunit monomer of 69 residues. All 15 trisaccharides bind to one side of the B-pentamer, providing further evidence that this side faces the cell membrane. The structural model is consistent with data from site-directed mutagenesis and binding of carbohydrate analogues, and allows the rational design of therapeutic Gb(3) analogues that block the attachment of toxin to cells.
引用
收藏
页码:1777 / 1788
页数:12
相关论文
共 67 条
  • [1] INVESTIGATION OF SHIGA-LIKE TOXIN BINDING TO CHEMICALLY SYNTHESIZED OLIGOSACCHARIDE SEQUENCES
    ARMSTRONG, GD
    FODOR, E
    VANMAELE, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) : 1160 - 1167
  • [2] A PHASE-I STUDY OF CHEMICALLY SYNTHESIZED VEROTOXIN (SHIGA-LIKE TOXIN) PK-TRISACCHARIDE RECEPTORS ATTACHED TO CHROMOSORB FOR PREVENTING HEMOLYTIC-UREMIC SYNDROME
    ARMSTRONG, GD
    ROWE, PC
    GOODYER, P
    ORRBINE, E
    KLASSEN, TP
    WELLS, G
    MACKENZIE, A
    LIOR, H
    BLANCHARD, C
    AUCLAIR, F
    THOMPSON, B
    RAFTER, DJ
    MCLAINE, PN
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 1042 - 1045
  • [3] CHOLESTEROL AND THE GOLGI-APPARATUS
    BRETSCHER, MS
    MUNRO, S
    [J]. SCIENCE, 1993, 261 (5126) : 1280 - 1281
  • [4] METHODS AND PROGRAMS FOR DIRECT-SPACE EXPLOITATION OF GEOMETRIC REDUNDANCIES
    BRICOGNE, G
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1976, 32 (SEP1): : 832 - 847
  • [5] FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES
    BRUNGER, AT
    [J]. NATURE, 1992, 355 (6359) : 472 - 475
  • [6] BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
  • [7] BRUNTON JL, 1990, BACTERIA, V11, P377
  • [8] RISK-FACTORS FOR THE PROGRESSION OF ESCHERICHIA-COLI O157-H7 ENTERITIS TO HEMOLYTIC-UREMIC SYNDROME
    CIMOLAI, N
    CARTER, JE
    MORRISON, BJ
    ANDERSON, JD
    [J]. JOURNAL OF PEDIATRICS, 1990, 116 (04) : 589 - 592
  • [9] Phenylalanine 30 plays an important role in receptor binding of verotoxin-1
    Clark, C
    Bast, D
    Sharp, AM
    StHilaire, PM
    Agha, R
    Stein, PE
    Toone, EJ
    Read, RJ
    Brunton, JL
    [J]. MOLECULAR MICROBIOLOGY, 1996, 19 (04) : 891 - 899
  • [10] INTERACTION OF VIBRIO-CHOLERAE ENTEROTOXIN WITH CELL-MEMBRANES
    CUATRECASAS, P
    [J]. BIOCHEMISTRY, 1973, 12 (18) : 3547 - 3558